Orphelia Pharma
Organization
Trials
TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide
Phase 1, Completed, 49 people, Oct 30, 2020
Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
Phase 1, Completed, 36 people, Jul 13, 2020
Sources: clinicaltrials.gov